,title,source,link,date
2,GSK Pharma Q2 Results Review -Vaccines Witness Pick-Up In Growth: Motilal Oswal,BQ Prime,news.google.com/articles/CBMidmh0dHBzOi8vd3d3LmJxcHJpbWUuY29tL3Jlc2VhcmNoLXJlcG9ydHMvZ3NrLXBoYXJtYS1xMi1yZXN1bHRzLXJldmlldy12YWNjaW5lcy13aXRuZXNzLXBpY2stdXAtaW4tZ3Jvd3RoLW1vdGlsYWwtb3N3YWzSAXpodHRwczovL3d3dy5icXByaW1lLmNvbS9hbXAvcmVzZWFyY2gtcmVwb3J0cy9nc2stcGhhcm1hLXEyLXJlc3VsdHMtcmV2aWV3LXZhY2NpbmVzLXdpdG5lc3MtcGljay11cC1pbi1ncm93dGgtbW90aWxhbC1vc3dhbA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
44,מניית GSK פארמה עולה בעקבות תוצאות חזקות לרבעון השלישי ותחזית צמיחה ...,Investing.com ישראל,news.google.com/articles/CBMiQ2h0dHBzOi8vaWwuaW52ZXN0aW5nLmNvbS9uZXdzL3N0b2NrLW1hcmtldC1uZXdzL2FydGljbGUtOTNDSC0zMTM1MzLSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
43,Le azioni di GSK Pharma sono in rialzo grazie ai solidi risultati del ...,Investing.com Italia,news.google.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_YW1wTW9kZT0x?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
8,"Anti-Cancer Drug Industry 2030 | Merck, Amgen, GlaxoSmithKline ...",Argyle Report,news.google.com/articles/CBMiZGh0dHBzOi8vd3d3LmFyZ3lsZXJlcG9ydC5jb20vbmV3cy9hbnRpLWNhbmNlci1kcnVnLWluZHVzdHJ5LTIwMzAtbWVyY2stYW1nZW4tZ2xheG9zbWl0aGtsaW5lLzM1OTQ5OC_SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
40,GSK Pharma hisseleri güçlü 3. çeyrek sonuçları ve olumlu büyüme ...,Investing.com Türkiye,news.google.com/articles/CBMilwFodHRwczovL3RyLmludmVzdGluZy5jb20vbmV3cy9zdG9jay1tYXJrZXQtbmV3cy9nc2stcGhhcm1hLWhpc3NlbGVyaS1ndWNsdS0zLWNleXJlay1zb251Y2xhci12ZS1vbHVtbHUtYnV5dW1lLWdvcnVudW11bnVuLWFyZG5kYW4teXVrc2VsZGktOTNDSC0yNTk3MDIx0gGjAWh0dHBzOi8vbS50ci5pbnZlc3RpbmcuY29tL25ld3Mvc3RvY2stbWFya2V0LW5ld3MvZ3NrLXBoYXJtYS1oaXNzZWxlcmktZ3VjbHUtMy1jZXlyZWstc29udWNsYXItdmUtb2x1bWx1LWJ1eXVtZS1nb3J1bnVtdW51bi1hcmRuZGFuLXl1a3NlbGRpLTkzQ0gtMjU5NzAyMT9hbXBNb2RlPTE?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
1,GSK Pharma shares rally following strong Q3 results and positive ...,Investing.com,news.google.com/articles/CBMijQFodHRwczovL3d3dy5pbnZlc3RpbmcuY29tL25ld3Mvc3RvY2stbWFya2V0LW5ld3MvZ3NrLXBoYXJtYS1zaGFyZXMtcmFsbHktZm9sbG93aW5nLXN0cm9uZy1xMy1yZXN1bHRzLWFuZC1wb3NpdGl2ZS1ncm93dGgtb3V0bG9vay05M0NILTMyMzAwMDbSAZUBaHR0cHM6Ly9tLmludmVzdGluZy5jb20vbmV3cy9zdG9jay1tYXJrZXQtbmV3cy9nc2stcGhhcm1hLXNoYXJlcy1yYWxseS1mb2xsb3dpbmctc3Ryb25nLXEzLXJlc3VsdHMtYW5kLXBvc2l0aXZlLWdyb3d0aC1vdXRsb29rLTkzQ0gtMzIzMDAwNj9hbXBNb2RlPTE?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
0,"Glaxosmithkline Pharmaceuticals share price Today Live Updates : Glaxosmithkline Pharmaceuticals closed today at ₹1457.3, up 0.84% from yesterday's ₹1445.15 | Mint",Mint,news.google.com/articles/CBMigwFodHRwczovL3d3dy5saXZlbWludC5jb20vbWFya2V0L2xpdmUtYmxvZy9nbGF4b3NtaXRoa2xpbmUtcGhhcm1hY2V1dGljYWxzLXNoYXJlLXByaWNlLWxpdmUtYmxvZy1mb3ItMDktbm92LTIwMjMtMTE2OTk0OTgzNjIxNTkuaHRtbNIBhwFodHRwczovL3d3dy5saXZlbWludC5jb20vbWFya2V0L2xpdmUtYmxvZy9nbGF4b3NtaXRoa2xpbmUtcGhhcm1hY2V1dGljYWxzLXNoYXJlLXByaWNlLWxpdmUtYmxvZy1mb3ItMDktbm92LTIwMjMvYW1wLTExNjk5NDk4MzYyMTU5Lmh0bWw?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-09
18,Peptide Antibiotics Industry to Witness Stunning Growth by 2030 ...,Argyle Report,news.google.com/articles/CBMijgFodHRwczovL3d3dy5hcmd5bGVyZXBvcnQuY29tL2dvbGYvcGVwdGlkZS1hbnRpYmlvdGljcy1pbmR1c3RyeS10by13aXRuZXNzLXN0dW5uaW5nLWdyb3d0aC1ieS0yMDMwLWdsYXhvc21pdGhrbGluZS1lbGktbGlsbHktdGhlcmF2YW5jZS8zMzY5OTIv0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-09
79,"Hepatitis B Vaccine (Recombinant) Market Size, Market Share, Data ...",GlobeNewswire,news.google.com/articles/CBMiwwFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMy8xMS8wOS8yNzc3MzI2LzAvZW4vSGVwYXRpdGlzLUItVmFjY2luZS1SZWNvbWJpbmFudC1NYXJrZXQtU2l6ZS1NYXJrZXQtU2hhcmUtRGF0YS1BbmFseXNpcy1hbmQtRm9yZWNhc3RzLTIwMjMtMjAzMC1NYXJrZXQtU3R1ZHktYnktUmF0aW9uYWxTdGF0Lmh0bWzSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-09
47,"Nasal Drug Delivery Technology Market Size, Players, Revenue Analysis 2023-2030",openPR,news.google.com/articles/CBMiXmh0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMjgzMjQ5L25hc2FsLWRydWctZGVsaXZlcnktdGVjaG5vbG9neS1tYXJrZXQtc2l6ZS1wbGF5ZXJzLXJldmVudWXSAV1odHRwczovL3d3dy5vcGVucHIuY29tL2FtcC8zMjgzMjQ5L25hc2FsLWRydWctZGVsaXZlcnktdGVjaG5vbG9neS1tYXJrZXQtc2l6ZS1wbGF5ZXJzLXJldmVudWU?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-09
